Sonnet BioTherapeutics Holdings (SONN) said Wednesday it priced an underwritten public offering of 1.11 million shares of common stock and common warrants to purchase up to 2.22 million shares.
Each share and accompanying common warrant is priced at $4.50, set at market value under Nasdaq Stock Market regulations, totaling about $5 million in gross proceeds, Sonnet BioTherapeutics said.
Each warrant grants the holder two shares at an exercise price of $4.50, with a five-year term. The offering is expected to close on or about Thursday, subject to customary closing conditions, the company said.
Sonnet BioTherapeutics shares jumped past 21% in recent trading.
Price: 5.09, Change: +0.89, Percent Change: +21.19
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。